drugset / Trial / NCT00232570
Quetiapine for the Treatment of Insomnia in Alzheimer's Disease
Unknown
18 enrolled
University of Vermont
AstraZeneca · collabNational Center for Research Resources (NCRR) · collab
Non-randomizedParallel-groupSingle-blindTreatment
Summary
The primary hypothesis is that quetiapine will improve sleep in persons with Alzheimer's Disease (AD), with higher doses producing greater total sleep time and sleep efficiency.
Timeline
- Start
- 2005-11
- Primary completion
- 2009-12
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | — | — |